Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases.

Marc Ladanyi , Pedram Argani , Juan Rosai , David S. Klimstra
Modern Pathology 11 ( 1) 65 -71

103
1998
The Genetic Basis of Transcriptional Heterogeneity for Basal-Like Features in Pancreatic Ductal Adenocarcinoma

Ralph H. Hruban , Olca Basturk , Michael Overholtzer , Kalyani Chadalavada
bioRxiv 548354

2019
Digital Pathology Operations at an NYC Tertiary Cancer Center During the First 4 Months of COVID-19 Pandemic Response

Victor E. Reuter , Meera Hameed , David S. Klimstra , Sahussapont J. Sirintrapun
Academic Pathology 8 237428952110102

2021
Lymph node micrometastases do not predict relapse in stage II colon cancer

Jorg Tschmelitsch , David S. Klimstra , Alfred M. Cohen
Annals of Surgical Oncology 7 ( 8) 601 -608

89
2000
Abstract B16: Using human patient-derived organoids to identify genetic dependencies in pancreatic cancer

Lindsey A. Baker , Hervé Tiriac , Vincenzo Corbo , Sylvia F. Boj
Clinical Cancer Research 22

1
2016
Genomic profiling of pancreas ductal adenocarcinoma (PDA), actionability, and correlation with clinical phenotype.

Emmet Jordan , Maeve Aine Lowery , Ryan Ptashkin , Ahmet Zehir
Journal of Clinical Oncology 34 4127 -4127

1
2016
Brain metastases (BM) in pancreatic ductal adenocarcinoma (PDAC): Clinical and molecular characteristics.

Emmet Jordan , Thomas Joseph Kaley , Marinela Capanu , Hayley Estrella
Journal of Clinical Oncology 35

2017
Regional differences in gallbladder cancer pathogenesis: Insights from a multi‐institutional comparison of tumor mutations

Raja R. Narayan , John M. Creasy , Debra A. Goldman , Mithat Gönen
Cancer 125 ( 4) 575 -585

14
2019
Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes

Winston Wong , Maeve A. Lowery , Michael F. Berger , Yelena Kemel
Cancer 125 ( 9) 1441 -1448

8
2019
Molecular profiling and analysis of genetic aberrations aimed at identifying potential therapeutic targets in fibrolamellar carcinoma of the liver

Imane El Dika , Anita S. Bowman , Michael F. Berger , Marinela Capanu
Cancer 126 ( 18) 4126 -4135

2020
Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas.

Yuxiang Wang , Aaron T. Wild , Sevin Turcan , Wei H. Wu
Science Advances 6 ( 17)

67
2020
Gastroenteropancreatic high-grade neuroendocrine carcinoma.

Halfdan Sorbye , Jonathan Strosberg , Eric Baudin , David S. Klimstra
Cancer 120 ( 18) 2814 -2823

357
2014
Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.

Eric C Sorenson , Raya Khanin , Zubin M Bamboat , Michael J Cavnar
PLOS ONE 12 ( 5)

13
2017
Immunohistochemical detection of the BRAF V600E mutant protein in colorectal neoplasms.

Efsevia Vakiani , Rona Yaeger , Sylvester Brooke , Yi Zhou
Applied Immunohistochemistry & Molecular Morphology 23 ( 6) 438 -443

12
2015
Acinar cell carcinoma of the pancreas and related neoplasms: a review

Olca Basturk , David S. Klimstra
Diagnostic Histopathology 18 ( 1) 8 -16

4
2012
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup

Chang S. Chan , Saurabh V. Laddha , Peter W. Lewis , Matthew S. Koletsky
Nature Communications 9 ( 1) 4158

155
2018